Tech Company Financing Transactions

Calyxo Funding Round

Ally Bridge Group, Janus Henderson Investors and Avidity Partners participated in a $40 million Series F capital raise for Calyxo. The round closed on 4/14/2026.

Transaction Overview

Company Name
Calyxo
Announced On
4/14/2026
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Series F
Investors

Ally Bridge Group (Lead Investor)

Janus Henderson Investors (Lead Investor)

Avidity Partners

CRG (Luke Düster)

Questa Capital (Ryan Drant)

Proceeds Purpose
The company intends to use the funds to expand its commercial infrastructure, advance clinical and health economic evidence generation through ongoing and future studies evaluating long-term outcomes and downstream healthcare utilization, and support continued innovation in kidney stone care.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
4473 Willow Rd. 100
Pleasanton, CA 94588
USA
Phone
(925) 526-5900
Website
www.calyxoinc.com
Email Address
[email protected]
Overview
Calyxo, Inc. was founded in February 2016 to address the profound need for improved kidney stone treatment. Kidney stone disease is a common problem that is painful and consumes vast amounts of healthcare resources each year. We are focused on delivering innovative solutions to better meet the needs of kidney stone patients and transform the care of this condition.
Profile
Calyxo LinkedIn Company Profile
Social Media
Calyxo Company Twitter Account
Company News
Calyxo News
Facebook
Calyxo on Facebook
YouTube
Calyxo on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Joe Catanese
  Joe Catanese LinkedIn Profile  Joe Catanese Twitter Account  Joe Catanese News  Joe Catanese on Facebook
Chief Financial Officer
Douglas Hughes
  Douglas Hughes LinkedIn Profile  Douglas Hughes Twitter Account  Douglas Hughes News  Douglas Hughes on Facebook
VP - Bus. Development
Jee Shin
  Jee Shin LinkedIn Profile  Jee Shin Twitter Account  Jee Shin News  Jee Shin on Facebook
VP - General Counsel
Chris Buchko
  Chris Buchko LinkedIn Profile  Chris Buchko Twitter Account  Chris Buchko News  Chris Buchko on Facebook
VP - Operations
Eric Steuben
  Eric Steuben LinkedIn Profile  Eric Steuben Twitter Account  Eric Steuben News  Eric Steuben on Facebook
VP - R & D
Ling Tong
  Ling Tong LinkedIn Profile  Ling Tong Twitter Account  Ling Tong News  Ling Tong on Facebook

 

 

Browse more venture capital transactions:

Prev: 4/14/2026: Stegra venture capital transaction
Next: 4/14/2026: Obriy AI venture capital transaction

 

Share this article

 

About Our Venture Capital Transactions Database

We do our best to report on every notable VC transaction. VC investment data records on this site are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2026. Gaebler Ventures. All rights reserved.